Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Manchester United PLC (MANU) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Manchester United PLCTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Manchester United PLC vs Zimmer Biomet Holdings Inc — how do they compare? Manchester United PLC trades at $22.39 (market cap $3.83B), while Zimmer Biomet Holdings Inc trades at $91.12 (market cap $17.63B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 4.6× Manchester United PLC's market cap, and Manchester United PLC pays the higher dividend (1.26%). Which is the better fit depends on your goals.

MANUZBH
Market Cap
$3.83B$17.63B
Sector
MediaHealth
52-Week High
$23.53$107.71
52-Week Low
$15.10$79.58
Enterprise Value
$4.75B$24.68B
Dividend Yield
1.26%1.05%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Manchester United PLC

Manchester United (MANU) trades at $22.23, up 0.18% on the day, with a bullish technical signal from moving averages. The company reported mixed quarterly earnings, beating estimates in Q2 2025 and Q1 2026 but missing in Q3 and Q4 2025. Revenue reached $666.51M in 2025, though net income remained negative at -$33.02M. Recent news highlights a major milestone with land secured for a new 100,000-seat stadium, a significant de-risking step for future growth.

The outlook is cautiously optimistic, driven by stadium development and Champions League qualification boosting future revenue. However, persistent net losses, high debt levels, and shareholder equity concerns pose risks. Analyst sentiment is mixed with 40% buy ratings, suggesting potential upside but requiring careful monitoring of profitability improvements.

Zimmer Biomet Holdings Inc

Zimmer Biomet (ZBH) trades at $91.12, down 2.81% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $97.67. The company reported Q1 2026 EPS of $2.09, beating expectations, and maintains strong profitability with a 70.03% gross margin. Recent news highlights expansion in Asia Pacific and a planned $1 billion share repurchase program in 2026, signaling confidence in future growth.

ZBH presents a balanced outlook with steady revenue growth and shareholder returns, but faces risks from rising debt levels and competitive pressures. The stock's current valuation near support at $91 offers potential upside to the consensus target, though investors should monitor execution on innovation and cost management amid industry headwinds.

Returns comparison

Trailing returns across standard periods

About Manchester United PLC

Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.

Read more on MANU

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH